Leadership at the intersection of health, ethics, technology, and law

            The current psychedelic revival has produced an unusually crowded field of self-proclaimed authorities and experts. Neuroscientists, psychiatrists, psychotherapists, trial participants, underground guides, religious practitioners, Indigenous knowledge holders, policy advocates, entrepreneurs, journalists, retreat operators, podcasters, and social-media personalities all make claims about what psychedelic substances are, what they do, and who should have access to them. 

Delegates at October’s UN biodiversity summit in Yerevan arrived with an awkward number in their briefing papers. The Cali Fund, created two years ago to collect a share of profits from users of genetic sequence data, had received only $6,000 against an expected $1 billion a year. 

As artificial intelligence becomes increasingly embedded in healthcare, its implications for people with disabilities warrant particular attention. 

On September 30, five prominent Harvard Law School alumni told a packed room about how the field of health law has developed, through the lens of the varied paths that led them to their careers. 

Medicine has long had a way to decide when someone is ready to practice alone: supervise them until they have earned it. Health AI is still looking for its version of that process.